General Cardiology Disease Fellowship

Peter Hagan, MB
Director, Cardiovascular Diseases Fellowship

Richard Weinberg, MD, PhD
Associate Director,
Cardiovascular Diseases Fellowship

Thank you for your interest in the University of Michigan Cardiovascular Disease Fellowship Program. Our goal is to help fellows develop to the fullest of their potential in a stimulating and supportive program. The University of Michigan, from the days of opening the first University Hospital in 1850, has a longstanding tradition of excellence in training leaders in cardiovascular disease. We have a diverse and internationally recognized faculty practicing in a state of the art facility at one of the greatest public universities in the world.

While we have a great tradition, faculty, facility and university, the greatest asset of all is our fellows. We are fortunate to recruit some of the brightest young talent in medicine. Additional strengths of our program include outstanding clinical training in all disciplines, a state of the art VA hospital staffed by UM faculty, a broad range of basic and clinical research opportunities, and leadership committed to trainee development and mentorship. Our clinical services are busy and growing, and fellows care for patients with a broad range of cardiovascular diseases. We believe first and foremost in producing well-trained clinical cardiologists. We believe in the critical role of a strong culture in the optimal performance of our program and in empowering our fellows to drive the culture.

Ann Arbor is a fabulous place to call home, and is frequently ranked among the best places to live in the US. Our current fellows are outstanding individuals and we are extremely fortunate and proud to work with such a fine group of people. We are confident that you will find Ann Arbor a great place to live and train, and we will do our best to help you reach your goals.

We appreciate your interest in our program and look forward to meeting you.

Sincerely,
Peter Hagan, MB, Program Director
Richard Weinberg, MD, PhD, Associate Program Director

APPLY

Curriculum

Research

The clinical and translational research programs outlined below are at the disposal of all cardiology fellows at the University of Michigan. Research opportunities are uniformly strong across disciplines, and fellows are encouraged to create new collaborations across the schools and institutes at the University. Over the course of training, fellows have been known to publish in high impact journals such as the Journal of the American College of Cardiology, Circulation, the Journal of the American Medical Association, and the New England Journal of Medicine.

Formal Clinical Research Programs

Ongoing Clinical Trials

Follow this link to the Clinical Trials website

Clinical Registries

MEDFIT — Preventive Cardiology Patient Registry
IRAD — International Registry on Aortic Dissection
CSR — Cardiac Sarcoid Global Registry
FMD — Global Fibromuscular Dysplasia Registry
MAQI — Michigan Anticoagulation Quality Improvement Registry
PHS — Project Healthy Schools Initiative
BRIDGE — Post Discharge Cardiac Patient Management Registry

Basic Science Research Opportunities

Follow this link for an in depth description of basic science research opportunities

Justus Anumonwo, PhD
- Researching molecular interactions involved in the regulation of cardiac ion channels
- Investigating arrhythmia mechanisms in animal models and in patient-specific, stem cell-derived cardiac myocytes
- Understanding excess adiposity induced electro-mechanical dysfunction of the heart
Omer Berenfeld, PhD
- Investigating the mechanisms of ventricular and atrial fibrillation with emphasis on translation of potential therapies from bench to bedside
James Brian Byrd, MD, MS
- Discovering novel biomarkers to guide the personalized treatment of resistant hypertension
- Understanding the role of mineralocorticoids in obesity-associated hypertension
Yuqing Chen, MD, PhD
- Understanding molecular mechanisms underlying the development and progression of diabetes-induced cardiovascular diseases (CVD) and stroke
Sharlene Mary Day, MD
- Understanding genetic and molecular pathways that underly diseases intrinsic to the myocardium, including ischemic cardiomyopathy and genetic cardiomyopathies such as hypertrophic cardiomyopathy
Daniel T Eitzman, MD
- Determining the impact of various genetic alterations on atherosclerosis and arterial thrombosis using in vivo mouse models
Todd J Herron, PhD
- Studying cardiovascular regeneration and the development of cell based therapies
Santhi Kalaichelvi Ganesh, MD
- Investigating the genetic basis of vascular diseases
David Ginsburg, MD
- Understanding the components of the blood clotting system and how disturbances in their function lead to human bleeding and blood-clotting disorders
Daniel R Goldstein, MD, PhD
- Focusing on how aging impacts inflammation during acute viral infections and during chronic inflammatory disorders such as atherosclerosis
Jose Jalife, MD
- Employing mathematical and biophysical concepts to increase the understanding of the mechanisms of life-threatening cardiac arrhythmias, from the molecule to the bedside
Yogen Kanthi, MD
- Investigating the molecular mechanisms of inflammation and thrombosis in vascular biology
Isom Lori, PhD
- Studying human patient-derived induced pluripotent stem cell neurons and cardiac myocytes to understand the mechanism of inherited epilepsy and co-morbid cardiac arrhythmias linked to mutations in sodium channel genes
David Joel Pinsky, MD
- Studying mechanisms driving hypoxic/ischemic modulation of vascular phenotype
Hector Valdivia, MD, PhD
- Using molecular, cellular, whole heart and intact animal approaches to elucidate basic mechanisms of excitation-contraction coupling and the role of calcium mishandling in the generation of ventricular arrhythmias and atrial fibrillation
Margaret Westfall, PhD
- Understanding the roles played by protein kinase C and downstream myofilament targets in the modulation of cardiac performance under physiological and pathophysiological conditions
Stephen Weiss, MD
- Investigating transcriptional regulators and proteolytic effectors that control cardiac development, vasculogenesis and angiogenesis in vivo, ex vivo as well as 3-dimensional model systems that recapitulate morphogenic and differentiation programs in vitro

NIH T32 Training Grant

The purpose of this NIH sponsored training grant is to provide an intensive research training experience in cardiovascular research. The program is designed for postdoctoral MD's or PhD's in preparation for independent investigative careers related to cardiovascular disease.
Follow this link for further information